THE ACTION OF GANGLIONIC BLOCKING DRUGS ON THE SYNAPTIC RESPONSES OF RAT SUBMANDIBULAR GANGLION CELLS
Open Access
- 1 January 1982
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 75 (1) , 151-168
- https://doi.org/10.1111/j.1476-5381.1982.tb08768.x
Abstract
1 The effects of tubocurarine, hexamethonium and trimetaphan on the synaptic currents of rat submandibular ganglion cells have been measured at 20°C by means of a two-microelectrode voltage-clamp system. The aim was to distinguish between the receptor-blocking and channel-blocking actions of those drugs, and to test for possible selectivity of action on the ‘fast’ and ‘slow’ acetylcholine-operated channels. 2 Tubocurarine had no effect on the amplitude of evoked synaptic currents (e.s.cs) or miniature synaptic currents (m.s.cs), except at concentrations exceeding 20 μm. The slow component of the e.s.c. was shortened by tubocurarine, this effect becoming more marked as the cell was hyperpolarized. The timecourse of m.s.cs, which have no slow component, was unaffected. 3 Hexamethonium (2–30 μm) caused a voltage-dependent reduction of e.s.c. amplitude, and voltage-dependent shortening of both fast and slow components of the e.s.c. M.s.cs were also shortened. 4 Trimetaphan (2–10 μm) reduced the amplitude of e.s.cs and m.s.cs. Neither component of the e.s.c. was shortened by trimetaphan; however, the slow component was reduced in amplitude more than the fast component, so that the overall duration of the e.s.c. appeared to be reduced. At higher concentrations (15–25 μIM) trimetaphan clearly shortened the fast component. 5 It is concluded that tubocurarine acts selectively on the slow ionic channels, the association rate constant being 2.8 × 106 m−1 s−1 at −80mV. Hexamethonium acts on both fast and slow channels, the association rate constants, at — 80 mV, being respectively 5.3 × 106 m−1 s−1 and 1.3 × 107 m−1 s−1. With both drugs, the association rate constant increases if the cell is hyperpolarized, this effect being more pronounced with hexamethonium than with tubocurarine. 6 The marked voltage-dependent reduction of e.s.c. amplitude by hexamethonium cannot be accounted for by open channel block, and requires an additional mechanism, the nature of which is discussed. 7 Trimetaphan, at low concentrations, acts in a way consistent with receptor block, and shows a degree of selectivity for the slow component of the e.s.c. 8 In an appendix, the effect of temporal dispersion of the time of opening of ionic channels on the amplitude and time-course of the composite synaptic response is analysed. It is concluded that the shortening of the time-constant of the e.s.c. decay by hexamethonium cannot, by itself, account for the drug's effect on e.s.c. amplitude.Keywords
This publication has 27 references indexed in Scilit:
- The modes of action of gallamineProceedings of the Royal Society of London. B. Biological Sciences, 1981
- Reaction of tetraethylammonium with the open and closed conformations of the acetylcholine receptor ionic channel complex.The Journal of general physiology, 1979
- A re-examination of curare action at the motor endplateProceedings of the Royal Society of London. B. Biological Sciences, 1978
- Decamethonium both opens and blocks endplate channels.Proceedings of the National Academy of Sciences, 1978
- Relaxation and fluctuations of membrane currents that flow through drug-operated channelsProceedings of the Royal Society of London. B. Biological Sciences, 1977
- Voltage-dependent effect of curare at the frog neuromuscular junctionNature, 1977
- Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.The Journal of general physiology, 1977
- The Inhibition of Sodium Currents in Myelinated Nerve by Quaternary Derivatives of LidocaineThe Journal of general physiology, 1973
- The kinetics of action of acetylcholine antagonists in smooth muscleProceedings of the Royal Society of London. B. Biological Sciences, 1966
- Classification and molecular pharmacology of ganglionic blocking agentsInternational Journal of Neuropharmacology, 1962